30+ unique clinical trials targeting a wide array of biomarkers including FGFR, KEAP1, RET, NOTCH1, ESR1, and MET.
Trial Matching at Tempus
provider networks and research institutions signed up for the network today
patients identified for enrollment clinical trials
trials in the network
Tempus generates, organizes, and analyzes extensive amounts of data through our next-generation sequencing lab, AI-assisted clinical data structuring capabilities, and connectivity with researchers across the network. We support providers in identifying relevant and actionable clinical trials for their patients.
Our proprietary clinical trial matching software enables real-time matches for relevant, open, and recruiting clinical trials. Tempus’ team of trained abstractors manually reviews all protocol-specific inclusion and exclusion eligibility criteria for trials in the TIME Trial Program.
The program is designed to provide access to thousands of physicians and patients to clinical trials and novel therapeutics, no matter where they are in the United States.
All sites and sponsors participating in the TIME Trial Program commit to a standard clinical trial agreement, a pre-negotiated budget, and the use of a central IRB for trial oversight. Additionally, Tempus’ dedicated, expert research liaisons support sites and sponsors in streamlining all recruitment and enrollment activities
The entire activation process is designed to take 14 days or less, and the site always makes the decision about particular studies for involvement.
Learn more about recent rapid activation success stories.Download
Highline Sciences, a specialized, full-service clinical CRO and consultancy focused on oncology, is now part of Tempus.
This is the future of healthcare.Contact Us
Thank you for your inquiry, we have sent an email to you with more information.